When did Sarepta Therapeutics, Inc. report Q4 2024 earnings?

Sarepta Therapeutics, Inc. (SRPT) reported Q4 2024 earnings on February 26, 2025 after market close.

What were Sarepta Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Sarepta Therapeutics, Inc. reported revenue of $658.4M and eps of $1.50 for Q4 2024.

Did Sarepta Therapeutics, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $631.0M by $27.4M. EPS beat the consensus estimate of $1.38 by $0.12.

Where can I find Sarepta Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-029973) directly on SEC EDGAR. The filing index links above go to sec.gov.

Sarepta Therapeutics, Inc. SRPT Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$658.4MBeat by $27.4M

EPS$1.50Beat by $0.12

Revenue estimate$631.0M

EPS estimate$1.38

Next report

Aug 5, 2026 (In 6 days)

Revenue estimate$366.4M

EPS estimate$0.49

Financials

Q4 2024

Income statement

See full

Net income$159.0M—

Balance sheet

See full

Cash & equivalents$1.1B+157%

Total debt$205.7M-22.2%

Total equity$1.5B+77.8%

Total assets$4.0B+21.4%

Cash flow

See full

CapEx$38.1M+100%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$11.61B+28.7%

Enterprise value$10.72B+20.9%

P/E49.4×—

Returns & leverage

See full

Return on equity19.7%+10.8pp

Debt / equity0.1×-0.2×

Current ratio4.2×+0.3×

Segments

By product

See full

Elevidys$384.2M+193%

Pmo Products$254.0M+8.6%

By segment

See full

All Other Segments$658.4M+112%

Versus estimates

Revenue

Q1 2026$730.8MBeat by $256.6M Q4 2025$442.9MBeat by $73.3M Q3 2025$399.4MBeat by $8.0M Q2 2025$611.1MBeat by $268.2M Q1 2025$744.9MBeat by $5.3M

Q4 2024$658.4MBeat by $27.4M

Diluted EPS

Q1 2026$3.16Beat by $2.18 Q4 2025-$3.58Miss by $2.55 Q3 2025-$0.13Miss by $0.14 Q2 2025$2.02Beat by $0.91 Q1 2025-$3.42Miss by $3.77

Q4 2024$1.50Beat by $0.12

Ask the moment Sarepta Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Sarepta Therapeutics, Inc. report Q4 2024 earnings?: Sarepta Therapeutics, Inc. (SRPT) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Sarepta Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Sarepta Therapeutics, Inc. reported revenue of $658.4M and eps of $1.50 for Q4 2024.
Did Sarepta Therapeutics, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $631.0M by $27.4M. EPS beat the consensus estimate of $1.38 by $0.12.
Where can I find Sarepta Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-029973) directly on SEC EDGAR. The filing index links above go to sec.gov.